Non-dosing in the EMD AML trial doesn't need to be announced because it's already obvious. The only aspect that needs to be announced is the new expected first dosing date. That has already happened, several times.
As for the other streams, yes it would be to protect IP and no news is good news.
RAC Price at posting:
$2.21 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)